Understand the source comparison
Best Peptides for Low Libido: Mechanism Comparison
Different peptides address distinct underlying mechanisms. Choosing the right compound depends on whether the libido deficit stems from central arousal pathways, hormonal axis suppression, or emotional/pair-bonding impairment. The table below compares the thre
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Different peptides address distinct underlying mechanisms. Choosing the right compound depends on whether the libido deficit stems from central arousal pathways, hormonal axis suppression, or emotional/pair-bonding impairment. The table below compares the three primary peptide classes used in libido research.
- PT-141 (Bremelanotide)
- Melanocortin receptor agonism
- MC4R in hypothalamus
- 1–3 hours post-injection
- FDA-approved for HSDD; two Phase 3 trials showing 25% responder rate vs 17% placebo
- Best for individuals with central arousal deficits and normal hormone levels; works independently of testosterone
- Kisspeptin-10
- GnRH secretion stimulation
- KISS1R on hypothalamic GnRH neurons
- 30–90 minutes for LH surge; weeks for sustained hormonal changes
- Multiple Phase 2 trials showing 18–24% testosterone increase in hypogonadal men
- Best for secondary hypogonadism or HPG axis suppression; restores endogenous production rather than replacing hormones
- Oxytocin
- Social bonding and reward pathway modulation
- OXTR in limbic system and cortex
- 20–45 minutes (intranasal)
- Moderate evidence in sexual satisfaction and arousal; strongest for partner-interaction contexts
- Best for emotional intimacy deficits and anhedonia; enhances rewarding aspects of sexual experience rather than raw desire